Login / Signup

Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.

Anna Masajtis-ZagajewskaJacek MajerMichal Nowicki
Published in: Journal of the renin-angiotensin-aldosterone system : JRAAS (2021)
The study showed that in patients with hypertension and metabolic syndrome, both losartan and eprosartan have a neutral effect on fasting and postfructose load serum uric acid concentration and its urinary excretion. This trial is registered with NCT04954560.
Keyphrases
  • uric acid
  • metabolic syndrome
  • insulin resistance
  • angiotensin ii
  • cardiovascular risk factors
  • clinical trial
  • liver failure
  • type diabetes
  • study protocol
  • randomized controlled trial
  • phase iii
  • phase ii